Drawing for Serial No. 88667826

USPTO serial 88667826

Serial No. 88667826

Reviewed by CopyMark Law Group

Reg. 6471690Status 700Renewal
Filing date
Status date
Registration date
Aug 31, 2021
Examiner
JACKSON, WILLIAM D
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with Serial No. 88667826?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,097*

Plus Government fees of $975

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Ian W. Gillies

Ian W. Gillies KNOBBE, MARTENS, OLSON & BEAR, LLP2040 MAIN STREET14TH FLOORIRVINE, CA 92614

Goods and services

ClassDescriptionStatusFirst use
001Reagents used for scientific and research use; reagents, namely, antibodies and antibody fragments for scientific and research useACTIVEJun 30, 2005
005Drugs, pharmaceuticals, cell preparations, vaccines and vaccine adjuvants, therapeutic antibodies and other reagents used in the diagnosis, prevention, monitoring and treatment of disease or disorders, namely, for cancer, infectious diseases, transplantation, inflammation and immune disordersACTIVEJun 30, 2005
042Medical and scientific research and development, namely, screening, evaluation, development and conducting clinical trials of therapeutic, preventative and diagnostic compositions and treatments; research in the fields of biochemistry, biotechnology, and clinical trials; pharmaceutical research and development; providing medical and scientific research information in the fields of pharmaceuticals, biochemistry, biotechnology, and clinical trials; providing medical and scientific research information in the fields of pharmaceuticals, biochemistry, biotechnology, and clinical trials via the internetACTIVEJun 30, 2005

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 31, 2026REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Aug 31, 2026REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Aug 31, 2026REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Aug 31, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 29, 2021SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Jul 28, 2021CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Jul 8, 2021SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Jul 7, 2021AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jun 25, 2021IUAFUSE AMENDMENT FILED—
Jun 25, 2021EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
May 13, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 11, 2021EX2GSOU EXTENSION 2 GRANTED—
May 11, 2021EXT2SOU EXTENSION 2 FILED—
May 11, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 11, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 9, 2020EX1GSOU EXTENSION 1 GRANTED—
Nov 9, 2020EXT1SOU EXTENSION 1 FILED—
Nov 9, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 12, 2020NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 17, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 17, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 26, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 11, 2020ALIEASSIGNED TO LIE—
Feb 5, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 5, 2020XAECEXAMINER'S AMENDMENT ENTERED—
Feb 5, 2020GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Feb 5, 2020GNEAEXAMINERS AMENDMENT E-MAILED—
Feb 5, 2020CNEAEXAMINERS AMENDMENT -WRITTEN—
Jan 29, 2020DOCKASSIGNED TO EXAMINER—
Oct 31, 2019MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Oct 30, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 28, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance